{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:15:46Z","timestamp":1783617346982,"version":"3.55.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"27","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,3]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Atypical hemolytic uremic syndrome (aHUS) is a rare thrombotic microangiopathy (TMA) characterized by microangiopathic hemolytic anemia, thrombocytopenia, and organ dysfunction, particularly affecting the kidneys and the central nervous system. It is caused by genetic variants or autoantibodies involved in dysregulation of the complement system. Pathogenic variants of the complement factor H (CFH) gene are associated with severe disease and may lead to life-threatening multiorgan failure during the acute phase. We report a case of CFH mutation-positive aHUS complicated by recurrent posterior reversible encephalopathy syndrome (PRES) during the course of treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 32-year-old woman presented with progressive fatigue and acute dyspnea. Laboratory tests revealed hemolytic anemia, thrombocytopenia, and severe acute kidney injury.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>A peripheral blood smear revealed schistocytes, consistent with TMA. On hospital day 1, she developed generalized tonic\u2013clonic seizures followed by respiratory arrest that required mechanical ventilation. Continuous hemodialysis was initiated for severe renal failure. After the exclusion of thrombotic thrombocytopenic purpura, typical hemolytic uremic syndrome, and secondary causes of TMA, a clinical diagnosis of aHUS was made. Genetic testing later revealed a pathogenic heterozygous CFH variant (c.3572C&gt;T, p.Ser1191Leu), confirming the diagnosis of aHUS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Anti-C5 monoclonal antibody (eculizumab) was initiated based on the clinical diagnosis of aHUS. Intensive care management, including mechanical ventilation, renal replacement therapy, plasma exchange, and strict blood pressure control, was also provided.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>During the course of the disease, she developed severe cardiomyopathy and recurrent PRES. Early initiation of complement inhibition combined with intensive care management resulted in complete neurological recovery, and the patient was discharged home without any sequelae.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>This case highlights that CFH mutation-positive aHUS can be complicated by severe multiorgan dysfunction, including cardiomyopathy and recurrent PRES. Early clinical recognition and prompt initiation of complement inhibition were central to the favorable outcome, while intensive blood pressure control and comprehensive supportive care may have contributed to neurological recovery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049593","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:00:25Z","timestamp":1783098025000},"page":"e49593","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A case report of atypical hemolytic uremic syndrome with a CFH mutation complicated by recurrent posterior reversible encephalopathy syndrome"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9325-537X","authenticated-orcid":false,"given":"Ryotaro","family":"Maruyama","sequence":"first","affiliation":[{"name":"Department of General Internal Medicine, Aizawa Hospital, Nagano, Japan"},{"name":"Department of Emergency and Critical Care Medicine, Aizawa Hospital, Nagano, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Aizawa Hospital, Nagano, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Momose","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Aizawa Hospital, Nagano, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Amemiya","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Aizawa Hospital, Nagano, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ion","family":"Terakawa","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Aizawa Hospital, Nagano, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Teshima","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Aizawa Hospital, Nagano, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chimura","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, Aizawa Hospital, Nagano, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyutaro","family":"Noju","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, Aizawa Hospital, Nagano, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryu","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, Aizawa Hospital, Nagano, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Shiroto","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, Aizawa Hospital, Nagano, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Suganuma","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, Aizawa Hospital, Nagano, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomokiyo","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Aizawa Hospital, Nagano, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260709","first-page":"7553","article-title":"An adult case of atypical hemolytic uremic syndrome presented with posterior reversible encephalopathy syndrome: successful response to late-onset eculizumab treatment.","volume":"10","author":"Medeni","year":"2018","journal-title":"Hematol Rep"},{"key":"R2-20260709","doi-asserted-by":"crossref","first-page":"326","DOI":"10.5414\/CN107958","article-title":"Renal recovery with eculizumab in atypical hemolytic uremic syndrome following prolonged dialysis.","volume":"82","author":"Povey","year":"2014","journal-title":"Clin Nephrol"},{"key":"R3-20260709","first-page":"e65274","article-title":"A rare case of atypical hemolytic uremic syndrome presenting as chronic interstitial nephritis.","volume":"16","author":"Muralidharan","year":"2024","journal-title":"Cureus"},{"key":"R4-20260709","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/ccr3.59","article-title":"How atypical can atypical hemolytic uremic syndrome be?","volume":"2","author":"Sajan","year":"2014","journal-title":"Clin Case Rep"},{"key":"R5-20260709","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2169\/internalmedicine.5716-20","article-title":"Renal damage in recurrent atypical hemolytic uremic syndrome associated with C3 p.Ile1157Thr gene mutation.","volume":"60","author":"Okabe","year":"2021","journal-title":"Intern Med"},{"key":"R6-20260709","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1582-4934.2008.00350.x","article-title":"The alternative complement pathway revisited.","volume":"12","author":"Harboe","year":"2008","journal-title":"J Cell Mol Med"},{"key":"R7-20260709","first-page":"1740","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults.","volume":"5","author":"Fakhouri","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R8-20260709","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1007\/s10157-018-1549-3","article-title":"Clinical characteristics and genetic backgrounds of Japanese patients with atypical hemolytic uremic syndrome.","volume":"22","author":"Fujisawa","year":"2018","journal-title":"Clin Exp Nephrol"},{"key":"R9-20260709","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2478\/bjmg-2021-0007","article-title":"Familial atypical hemolytic uremic syndrome with positive p.S1191L (c.3572C>T) mutation on the CFH gene: a single-center experience.","volume":"24","author":"Ersoy Dursun","year":"2021","journal-title":"Balkan J Med Genet"},{"key":"R10-20260709","doi-asserted-by":"crossref","first-page":"18265","DOI":"10.1038\/s41598-024-68736-6","article-title":"Annual trends in atypical haemolytic uremic syndrome management in Japan and factors influencing early diagnosis and treatment: a retrospective study.","volume":"14","author":"Tatematsu","year":"2024","journal-title":"Sci Rep"},{"key":"R11-20260709","first-page":"52","article-title":"Atypical hemolytic uremic syndrome post-kidney transplantation: two case reports and review of the literature.","volume":"1","author":"Alasfar","year":"2014","journal-title":"Front Med (Lausanne)"},{"key":"R13-20260709","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"R14-20260709","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1182\/blood.2022017860","article-title":"How I diagnose and treat atypical hemolytic uremic syndrome.","volume":"141","author":"Fakhouri","year":"2023","journal-title":"Blood"},{"key":"R15-20260709","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s40620-016-0288-3","article-title":"Improved renal recovery in patients with atypical hemolytic uremic syndrome following rapid initiation of eculizumab treatment.","volume":"30","author":"Walle","year":"2017","journal-title":"J Nephrol"},{"key":"R16-20260709","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/1744-9987.12763","article-title":"Atypical hemolytic-uremic syndrome: an update on pathophysiology, diagnosis, and treatment.","volume":"23","author":"Raina","year":"2019","journal-title":"Ther Apher Dial"},{"key":"R17-20260709","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12882-022-02672-3","article-title":"What is the impact of blood pressure on neurological symptoms and the risk of ESKD in primary and secondary thrombotic microangiopathies based on clinical presentation: a retrospective study.","volume":"23","author":"Halimi","year":"2022","journal-title":"BMC Nephrol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049593","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:00:49Z","timestamp":1783616449000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":16,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049593","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"2026-03-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}